DEA: Office of Diversion Control

Conference Information and Registration

This conference is closed.

2023 DEA SUPPLY CHAIN CONFERENCE
May 2-4, 2023
Houston, Texas

The Drug Enforcement Administration (DEA), Diversion Control Division, is hosting a Supply Chain Conference May 2-4, 2023, at the Westin Galleria Houston in Houston, Texas. This conference will offer those registered with the DEA as Manufacturers, Distributors, Pharmacies, Importers or Exporters the opportunity to meet, share information and discuss concerns.

This conference will offer those registered with the DEA as Manufacturers, Distributors, Pharmacies, Importers or Exporters the opportunity to meet, share information and discuss concerns. This will be a three-day conference. Day 1 will be for manufacturers and other registrants who need quota, and for all importers and exporters. Days 2 and 3 of the conference will be geared toward regulatory compliance personnel for mid-level and senior managers. A virtual component will be offered for those who are unable to attend in person.

View Agenda

DATES

Tuesday, May 2, 2023 through Thursday 4, 2023

HOTEL

The Westin Galleria Houston 5060 W Alabama Street Houston, TX 77056
General Session:  Galleria Ballroom; Located on the 3rd floor
Breakout 1:  Woodway I; Located on the 4th floor
Breakout 2:  Woodway II; Located on the 4th floor

AIRPORTS

George Bush Intercontinental Airport - 27 miles from hotel
William P Hobby Airport - 17 miles from hotel

PARKING

On-site self-parking: Complimentary
Valet parking: $25 daily; $49 overnight

REGISTRATION

A virtual component will be offered for those who are unable to attend in person.

NOTE: Conference attendees may choose to attend in-person OR virtually, but will not be able to register for both.

Maximum Capacity (in-person) = 500 attendees.

ATTIRE

Business casual attire is acceptable for this conference. Typically, meeting space temperatures in a hotel can vary; therefore, it is recommended to bring a sweater or a light jacket.

This conference is closed.

Any questions regarding this conference may be directed to: VDAT@dea.gov